Item 2.02.Results of Operation and Financial Condition.
On
Item 7.01. Regulation FD Disclosure.
The Company has updated its corporate deck, which is available in the "Investors & Media" portion of the Company's website at https://investor.precisionbiosciences.com.
The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01.Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Press release ofPrecision BioSciences, Inc. datedMay 9, 2022 . Cover Page Interactive Data File (embedded within the Inline XBRL document). 104
--------------------------------------------------------------------------------
© Edgar Online, source